ValGenesis Smart GxP Digital Validation Platform

ValGenesis, Inc. was founded in 2005 and is headquartered in Santa Clara, California. It built what it describes as the first fully digital validation lifecycle management system, replacing paper-based qualification and validation of equipment, processes, cleaning and computer systems in pharmaceutical and medical device manufacturing.

The Smart GxP platform groups a Validation Lifecycle Suite and a Process Lifecycle Suite. iVal handles AI-assisted authoring, automated test execution and traceability for CQV, CSV and CSA work. iClean automates cleaning validation with MACO calculations, ADE-based limits and 2D/3D equipment maps. iOps replaces paper logbooks with QR-enabled mobile forms, and iCMC and iCPV support tech transfer and continued process verification. The VAL AI assistant drafts documents and reviews execution evidence. It states that 30 of the top 50 life sciences companies use the platform.

• iVal: AI-assisted authoring, automated test execution and live anomaly flags for CQV and CSV.
• iClean: cleaning validation with automated MACO calculations and 2D/3D equipment maps.
• iOps: QR-enabled mobile logbooks for equipment use, cleaning and calibration.
• iCMC and iCPV: tech transfer and continued process verification in one suite.
• VAL AI assistant: governed AI that drafts documents and reviews execution evidence.
• Risk-based design: dynamic trace matrix and configurable workflows without custom code.

Vietnamese pharmaceutical plants preparing for EU-GMP inspections can manage equipment qualification and computer system validation digitally. Vaccine and biologics facilities can run cleaning validation and electronic logbooks. Medical device makers can maintain traceable validation records for export registrations.

The company reports validation cycles cut by up to 80% and audit observations cut by 90% with iVal. iClean is said to halve cleaning validation timelines. iOps reportedly reduces documentation labour by 70% with full traceability. Risk-based testing and impact assessment limit revisions to affected items only.

Regulators are encouraging risk-based computer software assurance (CSA) and paperless data integrity in GMP plants. Asian manufacturers, including CDMOs in India, Japan and Korea, are digitalising validation as they build new facilities for export markets. Vietnamese drug makers upgrading to EU-GMP and PIC/S will face heavier qualification and validation workloads that paper cannot handle efficiently.

Founded in 2005; ValGenesis, Inc. is headquartered in Santa Clara, California. Raised US$16 million in July 2025. Partnered with Hitachi Industry & Control Solutions (2025) and Validator K.K. (2026) for Japan, and with CAI (2025). Asian users include LOTTE Biologics, Eugia Pharmaceuticals, Biocon and Dr. Reddy's.